Syndecan-1 (CD138) expression is related to an aggressive phenotype and to poorer prognosis in breast carcinoma.

被引：0
|
作者：
Barbareschi, M
Aldovini, D
Maisonneuve, P
Cangi, MG
Pecciarini, L
Mauri, FA
Caffo, O
Galligioni, E
Dalla Palma, P
Doglioni, C
机构：
[1] Hosp Belluno, Dept Pathol, Belluno, Italy
[2] Hosp Trento, Dept Pathol, Trent, Italy
[3] Hosp Borgomanero, Dept Pathol, Borgomanero, Italy
[4] Ist Europeo Oncol, Div Epidemiol & Biostat, Milan, Italy
[5] Trento Hosp, Trent, Italy
来源：
MODERN PATHOLOGY | 2001年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
102
引用
收藏
页码：21A / 21A
页数：1
相关论文
共 50 条
  • [1] Syndecan-1 (CD138) expression is related to an aggressive phenotype and to poorer prognosis to breast carcinoma
    Barbareschi, M
    Aldovini, D
    Maisonneuve, P
    Cangi, MG
    Pecciarini, L
    Mauri, FA
    Caffo, O
    Galligioni, E
    Dalla Palma, P
    Doglioni, C
    LABORATORY INVESTIGATION, 2001, 81 (01) : 21A - 21A
  • [2] High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
    Barbareschi, M
    Maisonneuve, P
    Aldovini, D
    Cangi, MG
    Pecciarini, L
    Mauri, FA
    Veronese, S
    Caffo, O
    Lucenti, A
    Palma, PD
    Galligioni, E
    Doglioni, C
    CANCER, 2003, 98 (03) : 474 - 483
  • [3] Syndecan-1/CD138 Expression in Triple Negative Breast Carcinoma
    Husman, A. L.
    Adams, A. L.
    Cohen, C.
    Page, A. J.
    Sullivan, H. C.
    Oprea, G. M.
    LABORATORY INVESTIGATION, 2011, 91 : 44A - 44A
  • [4] Syndecan-1/CD138 Expression in Triple Negative Breast Carcinoma
    Husman, A. L.
    Adams, A. L.
    Cohen, C.
    Page, A. J.
    Sullivan, H. C.
    Oprea, G. M.
    MODERN PATHOLOGY, 2011, 24 : 44A - 44A
  • [5] Down expression of syndecan-1 (CD138) in nasopharyngeal carcinoma (NPC)
    Chen, CL
    MODERN PATHOLOGY, 2005, 18 : 211A - 212A
  • [6] Down expression of syndecan-1 (CD138) in nasopharyngeal carcinoma (NPC)
    Chen, CL
    LABORATORY INVESTIGATION, 2005, 85 : 211A - 212A
  • [7] Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis
    Chen, Chi-Long
    Ou, Da-Liang
    HUMAN PATHOLOGY, 2006, 37 (10) : 1279 - 1285
  • [8] A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer
    Kind, Simon
    Jaretzke, Annika
    Buescheck, Franziska
    Moeller, Katharina
    Dum, David
    Hoeflmayer, Doris
    Hinsch, Andrea
    Weidemann, Soren
    Fraune, Christoph
    Moeller-Koop, Christina
    Hube-Magg, Claudia
    Simon, Ronald
    Wilczak, Waldemar
    Lebok, Patrick
    Witzel, Isabell
    Mueller, Volkmar
    Schmalfeldt, Barbara
    Paluchowski, Peter
    Wilke, Christian
    Heilenkoetter, Uwe
    von Leffern, Ingo
    Krech, Till
    Krech, Rainer H.
    von der Assen, Albert
    Bawahab, Ahmed Abdulwahab
    Burandt, Eike
    MOLECULAR CARCINOGENESIS, 2019, 58 (12) : 2306 - 2315
  • [9] Syndecan-1 (CD138) expression in adenocarcinomas of the endometrium
    Willis, C
    Olson, S
    Washington, K
    Shappell, H
    MODERN PATHOLOGY, 2003, 16 (01) : 214A - 214A
  • [10] Syndecan-1 (CD138) expression in adenocarcinomas of the endometrium
    Willis, C
    Olson, S
    Washington, K
    Shappell, H
    LABORATORY INVESTIGATION, 2003, 83 (01) : 214A - 214A
12345